tiprankstipranks
Advertisement
Advertisement

AU:AVE Stock Latest News

Avecho launches no-cost facility to sell small shareholdings
Company AnnouncementsAvecho launches no-cost facility to sell small shareholdings
15h ago
Avecho secures strong shareholder backing at 2026 AGM as all put resolutions pass
PremiumCompany Announcements
Avecho secures strong shareholder backing at 2026 AGM as all put resolutions pass
1d ago
Avecho strengthens balance sheet as Phase III insomnia trial nears key read-out
PremiumCompany Announcements
Avecho strengthens balance sheet as Phase III insomnia trial nears key read-out
2d ago
Avecho Director Resigns as CBD Insomnia Program Enters Critical Phase
PremiumCompany Announcements
Avecho Director Resigns as CBD Insomnia Program Enters Critical Phase
2d ago
Avecho readies Phase III interim analysis on CBD insomnia capsule amid surging sleep market
PremiumCompany Announcements
Avecho readies Phase III interim analysis on CBD insomnia capsule amid surging sleep market
3d ago
Avecho Secures A$1.98m R&D Tax Refund to Advance CBD Insomnia Program
PremiumCompany AnnouncementsAvecho Secures A$1.98m R&D Tax Refund to Advance CBD Insomnia Program
6d ago
Avecho hits key milestone in Phase III CBD insomnia trial ahead of interim data
Premium
Company Announcements
Avecho hits key milestone in Phase III CBD insomnia trial ahead of interim data
6d ago
Avecho director reshapes indirect stake as options exercised and lapse
Premium
Company Announcements
Avecho director reshapes indirect stake as options exercised and lapse
14d ago
Avecho seeks ASX quotation for nearly 150m new shares
PremiumCompany Announcements
Avecho seeks ASX quotation for nearly 150m new shares
14d ago
Avecho lifts cash and streamlines capital ahead of pivotal CBD insomnia trial milestone
PremiumCompany Announcements
Avecho lifts cash and streamlines capital ahead of pivotal CBD insomnia trial milestone
16d ago
Avecho Seeks ASX Quotation for Newly Issued Shares
PremiumCompany Announcements
Avecho Seeks ASX Quotation for Newly Issued Shares
21d ago
Avecho appoints new company secretary to strengthen ASX governance
PremiumCompany Announcements
Avecho appoints new company secretary to strengthen ASX governance
26d ago
Avecho Flags Imminent Option Expiry as It Advances CBD Insomnia Trial
PremiumCompany AnnouncementsAvecho Flags Imminent Option Expiry as It Advances CBD Insomnia Trial
28d ago
Avecho Exceeds Phase III Insomnia Trial Target as Key Interim Read-Out Nears
Premium
Company Announcements
Avecho Exceeds Phase III Insomnia Trial Target as Key Interim Read-Out Nears
29d ago
Avecho sets 2026 AGM date and shifts to digital meeting materials
Premium
Company Announcements
Avecho sets 2026 AGM date and shifts to digital meeting materials
1M ago
Avecho to Showcase CBD Insomnia Program at NWR Healthcare Conference
PremiumCompany Announcements
Avecho to Showcase CBD Insomnia Program at NWR Healthcare Conference
2M ago
Avecho hits key Phase III recruitment milestone in CBD insomnia trial
PremiumCompany Announcements
Avecho hits key Phase III recruitment milestone in CBD insomnia trial
3M ago
Avecho Files Updated Corporate Governance Statement and Appendix 4G with ASX
PremiumCompany Announcements
Avecho Files Updated Corporate Governance Statement and Appendix 4G with ASX
3M ago
Avecho Widens Annual Loss Despite Higher Revenue as Development Spending Continues
PremiumCompany Announcements
Avecho Widens Annual Loss Despite Higher Revenue as Development Spending Continues
3M ago
Avecho nears key Phase III milestone as CEO showcases CBD insomnia program at healthcare forum
PremiumCompany AnnouncementsAvecho nears key Phase III milestone as CEO showcases CBD insomnia program at healthcare forum
4M ago
Avecho Advances Phase III CBD Insomnia Trial, Raises Capital and Secures US/EU Patent Wins
Premium
Company Announcements
Avecho Advances Phase III CBD Insomnia Trial, Raises Capital and Secures US/EU Patent Wins
4M ago
Avecho Nears Completion of Recruitment for Phase III CBD Trial
Premium
Company Announcements
Avecho Nears Completion of Recruitment for Phase III CBD Trial
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >